Bringing Cell Therapy From Oncology to Autoimmune Disease Will Present New and Unique Challenges
March 8th 2024Peter A. Merkel, MD, MPH, the chief of the Division of Rheumatology and a professor of medicine and professor of epidemiology at Penn Medicine, discussed the significant challenges in this field, but also expressed optimism for the future.
Long-Term Effects of CAR-T on Children’s Brains Remain Largely Unknown and More Research is Needed
February 26th 2024Juliane Gust, MD, PhD, an assistant professor of neurology at University of Washington, Seattle Children's, discussed a study that is currently underway via the NIH’s CARnation Consortium that will seek to address this gap in knowledge.
Slow-and-Steady Is the Right Approach for Evaluating Cell Therapy for Autoimmune Diseases
February 18th 2024Peter A. Merkel, MD, MPH, the chief of the Division of Rheumatology and a professor of medicine and professor of epidemiology at Penn Medicine, discussed clinical trial design considerations for this emerging field.